Measuring inflammation in the vitreous and retina: a narrative review.
Kale, Aditya U Serrano, Alba Liu, Xiaoxuan Balasubramaniam, Balini Keane, Pearse A Moore, David J Llorenç, Victor Denniston, Alastair K
Kale, Aditya U
Serrano, Alba
Liu, Xiaoxuan
Balasubramaniam, Balini
Keane, Pearse A
Moore, David J
Llorenç, Victor
Denniston, Alastair K
Abstract
Uveitis consists of a group of syndromes characterised by intraocular inflammation, accounting for up to 15% of visual loss in the western world and 10% worldwide. Assessment of intraocular inflammation has been limited to clinician-dependent, subjective grading. Developments in imaging technology, such as optical coherence tomography (OCT), have enabled the development of objective, quantitative measures of inflammatory activity. Important quantitative metrics including central macular thickness and vitreous signal intensity allow longitudinal monitoring of disease activity and can be used in conjunction with other imaging modalities enabling holistic assessment of ocular inflammation. Ongoing work into the validation of instrument-based measures alongside development of core outcome sets is crucial for standardisation of clinical trial endpoints and developing guidance for quantitative multi-modal imaging approaches. This review outlines methods of grading inflammation in the vitreous and retina, with a focus on the use of OCT as an objective measure of disease activity.
Citations
Altmetric:
Date
2022-04-12
Type
Article
Subject
Ophthalmology, Practice of medicine
Citation
Kale AU, Serrano A, Liu X, Balasubramaniam B, Keane PA, Moore DJ, Llorenç V, Denniston AK. Measuring Inflammation in the Vitreous and Retina: A Narrative Review. Ocul Immunol Inflamm. 2023 May;31(4):768-777. doi: 10.1080/09273948.2022.2049316. Epub 2022 Apr 12.
Journal / Source Title
Ocular Immunology and Inflammation
DOI
10.1080/09273948.2022.2049316
PMID
35412855
Publisher
Informa Healthcare
Publisher’s URL
http://www.tandfonline.com/loi/ioii20